Both metabolite networks are related with sn-glycerol 3-phosphate, melatonin, 5’-Methylthioadenosine and diphosphate, indicating their importance in associating with trastuzumab therapy response in HER2-positive GC. Here, ERBB2 is linked to gastric cancer.